GenVec Inc. Of Gaithersburg Reports Second-Quarter Net Loss of $3M
Posted on: Thursday, 4 August 2005, 21:00 CDT
GenVec Inc., of Gaithersburg, a biopharmaceutical company developing treatments for cancer, heart disease and vision
loss, and vaccines for infectious diseases, reported a second-quarter net loss of $3 million, or 5 cents per diluted share, on revenue of $7.3 million, versus a net loss of $4.8 million, or 9 cents per diluted share, on revenue of $3.2 million in the prior-year quarter.Source: The Daily Record (Baltimore)
Related Articles
- Alcatel posts bigger-than-expected net loss
- Telecom loss claim slashed to $73.4m
- IDT Reduces Losses, Looks to Offer Local Telephone Service in New Jersey Area
- Amazon.com Narrows 1st-Quarter Loss
- Epilepsy Drug May Spark Weight Loss
- Drug Slows Alzheimer's Memory Loss
- NASA Finds Wide Annual Fluctuations in Arctic Ozone Loss
- Study Links Bone Loss, Blood-Lead Levels
- Comcast Corp. Reports Smaller 4Q Loss
- Alcatel posts fourth quarter loss, forecasts sales drop early 2003
Rating: 2.7 / 5 (10 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds